ÂÜÀòÂÒÂ×

Rachel E. Sobel, DrPH, FISPE, currently serves as Vice President and Head of Pharmacoepidemiology at Regeneron. Previously, Rachel held the position of Executive Director and Head of Pharmacoepidemiology at UBC and served as Senior Director and Group Lead in Epidemiology for Global Innovative Pharma at Pfizer, among other roles. Rachel's early career included a position as Research Coordinator in the Rheumatology Division at the Hospital for Special Surgery. Education includes a DrPH in Pharmacoepidemiology and an MPH in Environmental Health Sciences, both from Columbia University Mailman School of Public Health.